{"id":"sl-401","safety":{"commonSideEffects":[{"effect":"Sinus tachycardia","drugRate":"100.0%","organSystem":"Cardiac disorders","placeboRate":"","totalAtRisk":1,"totalAffected":1,"trialsReporting":1},{"effect":"Appendicitis","drugRate":"100.0%","organSystem":"Infections and infestations","placeboRate":"","totalAtRisk":1,"totalAffected":1,"trialsReporting":1},{"effect":"Alanine aminotransferase increased","drugRate":"100.0%","organSystem":"Investigations","placeboRate":"","totalAtRisk":1,"totalAffected":1,"trialsReporting":1},{"effect":"Pain in extremity","drugRate":"100.0%","organSystem":"Musculoskeletal and connective tissue disorders","placeboRate":"","totalAtRisk":1,"totalAffected":1,"trialsReporting":1},{"effect":"Peripheral sensory neuropathy","drugRate":"100.0%","organSystem":"Nervous system disorders","placeboRate":"","totalAtRisk":1,"totalAffected":1,"trialsReporting":1},{"effect":"Anxiety","drugRate":"100.0%","organSystem":"Psychiatric disorders","placeboRate":"","totalAtRisk":1,"totalAffected":1,"trialsReporting":1},{"effect":"Anaemia","drugRate":"0.0%","organSystem":"Blood and lymphatic system disorders","placeboRate":"","totalAtRisk":1,"totalAffected":0,"trialsReporting":1},{"effect":"Leukocytosis","drugRate":"0.0%","organSystem":"Blood and lymphatic system disorders","placeboRate":"","totalAtRisk":1,"totalAffected":0,"trialsReporting":1},{"effect":"Leukopenia","drugRate":"0.0%","organSystem":"Blood and lymphatic system disorders","placeboRate":"","totalAtRisk":1,"totalAffected":0,"trialsReporting":1},{"effect":"Lymphadenopathy","drugRate":"0.0%","organSystem":"Blood and lymphatic system disorders","placeboRate":"","totalAtRisk":1,"totalAffected":0,"trialsReporting":1},{"effect":"Lymphopenia","drugRate":"0.0%","organSystem":"Blood and lymphatic system disorders","placeboRate":"","totalAtRisk":1,"totalAffected":0,"trialsReporting":1},{"effect":"Neutropenia","drugRate":"0.0%","organSystem":"Blood and lymphatic system disorders","placeboRate":"","totalAtRisk":1,"totalAffected":0,"trialsReporting":1},{"effect":"Thrombocytopenia","drugRate":"0.0%","organSystem":"Blood and lymphatic system disorders","placeboRate":"","totalAtRisk":1,"totalAffected":0,"trialsReporting":1},{"effect":"Atrial fibrillation","drugRate":"0.0%","organSystem":"Cardiac disorders","placeboRate":"","totalAtRisk":1,"totalAffected":0,"trialsReporting":1},{"effect":"Palpitations","drugRate":"0.0%","organSystem":"Cardiac disorders","placeboRate":"","totalAtRisk":1,"totalAffected":0,"trialsReporting":1},{"effect":"Pericardial effusion","drugRate":"0.0%","organSystem":"Cardiac disorders","placeboRate":"","totalAtRisk":1,"totalAffected":0,"trialsReporting":1},{"effect":"Tachycardia","drugRate":"0.0%","organSystem":"Cardiac disorders","placeboRate":"","totalAtRisk":1,"totalAffected":0,"trialsReporting":1},{"effect":"Ventricular tachycardia","drugRate":"0.0%","organSystem":"Cardiac disorders","placeboRate":"","totalAtRisk":1,"totalAffected":0,"trialsReporting":1},{"effect":"Vision blurred","drugRate":"0.0%","organSystem":"Eye disorders","placeboRate":"","totalAtRisk":1,"totalAffected":0,"trialsReporting":1},{"effect":"Abdominal distension","drugRate":"0.0%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":1,"totalAffected":0,"trialsReporting":1},{"effect":"Abdominal pain","drugRate":"0.0%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":1,"totalAffected":0,"trialsReporting":1},{"effect":"Abdominal pain upper","drugRate":"0.0%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":1,"totalAffected":0,"trialsReporting":1},{"effect":"Constipation","drugRate":"0.0%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":1,"totalAffected":0,"trialsReporting":1},{"effect":"Diarrhoea","drugRate":"0.0%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":1,"totalAffected":0,"trialsReporting":1},{"effect":"Dry mouth","drugRate":"0.0%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":1,"totalAffected":0,"trialsReporting":1},{"effect":"Dyspepsia","drugRate":"0.0%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":1,"totalAffected":0,"trialsReporting":1},{"effect":"Dysphagia","drugRate":"0.0%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":1,"totalAffected":0,"trialsReporting":1},{"effect":"Flatulence","drugRate":"0.0%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":1,"totalAffected":0,"trialsReporting":1},{"effect":"Gastrointestinal haemorrhage","drugRate":"0.0%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":1,"totalAffected":0,"trialsReporting":1},{"effect":"Gastrointestinal pain","drugRate":"0.0%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":1,"totalAffected":0,"trialsReporting":1},{"effect":"Gastrooesophageal reflux disease","drugRate":"0.0%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":1,"totalAffected":0,"trialsReporting":1},{"effect":"Gingival bleeding","drugRate":"0.0%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":1,"totalAffected":0,"trialsReporting":1},{"effect":"Gingival pain","drugRate":"0.0%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":1,"totalAffected":0,"trialsReporting":1},{"effect":"Haematochezia","drugRate":"0.0%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":1,"totalAffected":0,"trialsReporting":1},{"effect":"Haemorrhoids","drugRate":"0.0%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":1,"totalAffected":0,"trialsReporting":1},{"effect":"Melaena","drugRate":"0.0%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":1,"totalAffected":0,"trialsReporting":1},{"effect":"Nausea","drugRate":"0.0%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":1,"totalAffected":0,"trialsReporting":1},{"effect":"Stomatitis","drugRate":"0.0%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":1,"totalAffected":0,"trialsReporting":1},{"effect":"Toothache","drugRate":"0.0%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":1,"totalAffected":0,"trialsReporting":1},{"effect":"Vomiting","drugRate":"0.0%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":1,"totalAffected":0,"trialsReporting":1},{"effect":"Asthenia","drugRate":"0.0%","organSystem":"General disorders","placeboRate":"","totalAtRisk":1,"totalAffected":0,"trialsReporting":1},{"effect":"Chest discomfort","drugRate":"0.0%","organSystem":"General disorders","placeboRate":"","totalAtRisk":1,"totalAffected":0,"trialsReporting":1},{"effect":"Chest pain","drugRate":"0.0%","organSystem":"General disorders","placeboRate":"","totalAtRisk":1,"totalAffected":0,"trialsReporting":1},{"effect":"Chills","drugRate":"0.0%","organSystem":"General disorders","placeboRate":"","totalAtRisk":1,"totalAffected":0,"trialsReporting":1},{"effect":"Early satiety","drugRate":"0.0%","organSystem":"General disorders","placeboRate":"","totalAtRisk":1,"totalAffected":0,"trialsReporting":1},{"effect":"Fatigue","drugRate":"0.0%","organSystem":"General disorders","placeboRate":"","totalAtRisk":1,"totalAffected":0,"trialsReporting":1},{"effect":"Gait disturbance","drugRate":"0.0%","organSystem":"General disorders","placeboRate":"","totalAtRisk":1,"totalAffected":0,"trialsReporting":1},{"effect":"Generalised oedema","drugRate":"0.0%","organSystem":"General disorders","placeboRate":"","totalAtRisk":1,"totalAffected":0,"trialsReporting":1},{"effect":"Influenza like illness","drugRate":"0.0%","organSystem":"General disorders","placeboRate":"","totalAtRisk":1,"totalAffected":0,"trialsReporting":1},{"effect":"Nodule","drugRate":"0.0%","organSystem":"General disorders","placeboRate":"","totalAtRisk":1,"totalAffected":0,"trialsReporting":1}],"seriousAdverseEvents":[{"event":"Pyrexia","detail":"Infections and infestations. 1 trial(s).","severity":"serious","incidence":"100.0%"},{"event":"Cardiopulmonary failure","detail":"Cardiac disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Abdominal pain","detail":"Gastrointestinal disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Abdominal wall haematoma","detail":"Gastrointestinal disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Multiple organ dysfunction syndrome","detail":"General disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Pneumonia","detail":"Infections and infestations. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Hyperkalaemia","detail":"Metabolism and nutrition disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Acute kidney injury","detail":"Renal and urinary disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Urinary tract disorder","detail":"Renal and urinary disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Dyspnoea","detail":"Respiratory, thoracic and mediastinal disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Pneumonitis","detail":"Respiratory, thoracic and mediastinal disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Capillary leak syndrome","detail":"Vascular disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Embolism","detail":"Vascular disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Shock haemorrhagic","detail":"Vascular disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Gastrointestinal haemorrhage","detail":"Gastrointestinal disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Leukocytosis","detail":"Blood and lymphatic system disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Pancreatitis","detail":"Gastrointestinal disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Cholecystitis","detail":"Hepatobiliary disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Cholelithiasis","detail":"Hepatobiliary disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Cellulitis","detail":"Infections and infestations. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Clostridium difficile colitis","detail":"Infections and infestations. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Lung infection","detail":"Infections and infestations. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Parotitis","detail":"Infections and infestations. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Pneumonia pseudomonal","detail":"Infections and infestations. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Tracheobronchitis","detail":"Infections and infestations. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Upper respiratory tract infection","detail":"Infections and infestations. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Urinary tract infection","detail":"Infections and infestations. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Back pain","detail":"Musculoskeletal and connective tissue disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Cerebral infarction","detail":"Nervous system disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Cerebrovascular accident","detail":"Nervous system disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"}]},"_chembl":null,"_sources":{"safety.commonSideEffects":{"url":"","method":"deterministic","source":"ClinicalTrials.gov (1 trials)","rawText":"","confidence":1,"sourceType":"ctgov_results","retrievedAt":"2026-04-20T10:15:34.526078+00:00"}},"_dailymed":null,"_scrapedAt":"2026-03-28T05:28:39.785Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":2,"lastValidatedAt":"2026-04-20T10:15:41.384965+00:00","fieldsConflicting":0,"overallConfidence":0.95},"trialDetails":[{"nctId":"NCT06498973","phase":"PHASE1","title":"Tagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML and MDS Following Donor Hematopoietic Cell Transplant","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2025-01-28","conditions":"Acute Myeloid Leukemia, Myelodysplastic Syndrome","enrollment":43},{"nctId":"NCT04216524","phase":"PHASE2","title":"Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2020-05-29","conditions":"Blastic Plasmacytoid Dendritic Cell Neoplasm","enrollment":40},{"nctId":"NCT07148180","phase":"PHASE1, PHASE2","title":"A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and Venetoclax","status":"RECRUITING","sponsor":"Jacqueline Garcia, MD","startDate":"2026-02-02","conditions":"Acute Myeloid Leukaemia (AML), Leukemia, Blood Cancer","enrollment":31},{"nctId":"NCT05038592","phase":"PHASE1, PHASE2","title":"Phase I/II Study of Tagraxofusp in Combination With Decitabine for Patients With Myelomonocytic/Myeloproliferative Neoplasm and High Risk Myelodysplastic Syndromes","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2022-03-04","conditions":"Chronic Myelomonocytic Leukemia, Chronic Myelomonocytic Leukemia-1, Chronic Myelomonocytic Leukemia-2","enrollment":64},{"nctId":"NCT07007052","phase":"PHASE2","title":"Phase II Study Evaluating the Efficacy and Safety of the Combination of Tagraxofusp and Venetoclax in Treatment-naive Blastic Plasmacytoid Dendritic Cell Neoplasm Patients","status":"NOT_YET_RECRUITING","sponsor":"French Innovative Leukemia Organisation","startDate":"2025-12-01","conditions":"Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)","enrollment":33},{"nctId":"NCT03113643","phase":"PHASE1","title":"SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)","status":"RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2017-06-26","conditions":"Acute Myeloid Leukemia, Myelodysplastic Syndrome, Blastic Plasmacytoid Dendritic Cell Neoplasm","enrollment":72},{"nctId":"NCT05032183","phase":"PHASE1, PHASE2","title":"Tagraxofusp and Low-Intensity Chemotherapy for the Treatment of CD123 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma","status":"TERMINATED","sponsor":"M.D. Anderson Cancer Center","startDate":"2022-02-17","conditions":"Recurrent Adult Lymphoblastic Lymphoma, Recurrent B Acute Lymphoblastic Leukemia, Recurrent T Acute Lymphoblastic Leukemia","enrollment":4},{"nctId":"NCT02268253","phase":"PHASE1, PHASE2","title":"Tagraxofusp (SL-401) in Participants With Chronic Myelomonocytic Leukemia (CMML) and Myelofibrosis (MF)","status":"COMPLETED","sponsor":"Stemline Therapeutics, Inc.","startDate":"2016-02-10","conditions":"Myelofibrosis, Chronic Myelomonocytic Leukemia","enrollment":82},{"nctId":"NCT02270463","phase":"PHASE1, PHASE2","title":"SL-401 as Consolidation Therapy in Patients With Adverse Risk Acute Myeloid Leukemia in First Complete Remission","status":"TERMINATED","sponsor":"Stemline Therapeutics, Inc.","startDate":"2015-02","conditions":"Acute Myeloid Leukemia","enrollment":16},{"nctId":"NCT02113982","phase":"PHASE1, PHASE2","title":"Tagraxofusp in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm or Acute Myeloid Leukemia","status":"COMPLETED","sponsor":"Stemline Therapeutics, Inc.","startDate":"2014-09","conditions":"Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), Acute Myeloid Leukemia (AML)","enrollment":138},{"nctId":"NCT04317781","phase":"PHASE2","title":"Tagraxofusp in Treating Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm After Stem Cell Transplant","status":"TERMINATED","sponsor":"M.D. Anderson Cancer Center","startDate":"2020-03-27","conditions":"Blastic Plasmacytoid Dendritic Cell Neoplasm","enrollment":3},{"nctId":"NCT02661022","phase":"PHASE1, PHASE2","title":"SL-401 in Combination With Pomalidomide and Dexamethasone in Relapsed or Relapsed and Refractory Multiple Myeloma","status":"TERMINATED","sponsor":"Stemline Therapeutics, Inc.","startDate":"2016-01","conditions":"Multiple Myeloma","enrollment":9},{"nctId":"NCT05720988","phase":"PHASE1","title":"Tagraxofusp to Eradicate Measurable Residual Disease in Patients With Acute Myeloid Leukemia","status":"WITHDRAWN","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2024-08-03","conditions":"Acute Myeloid Leukemia","enrollment":""},{"nctId":"NCT00397579","phase":"PHASE1, PHASE2","title":"DT388IL3 Fusion Protein in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2013-05","conditions":"Leukemia, Myelodysplastic Syndromes, Blastic Plasmacytoid Dendritic Cell Neoplasm","enrollment":11}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":40,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_1","status":"active","brandName":"SL-401","genericName":"SL-401","companyName":"Dana-Farber Cancer Institute","companyId":"dana-farber-cancer-institute","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":5,"visitCount":2,"trialStats":{"total":2,"withResults":1},"validation":{"fieldsValidated":2,"lastValidatedAt":"2026-04-20T10:15:41.384965+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":false,"safety":true,"trials":true,"score":2}}